BIOLOGICS MARKET ANALYSIS

Biologics Market, By Product (Monoclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cellular-based Biologics, Gene-based Biologics, and Others), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : May 2023
Code : CMI2663
Pages :210
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Biologics Market- Regional Analysis

Among region, North America is expected to gain highest share in the market during the forecast period, owing to increasing prevalence of chronic, infectious, and autoimmune diseases. Biologics are used to treat a variety of conditions such as cancer, and thus, increasing burden of cancer boosts demand for of biologics. According to the American Cancer Society, in January 2022, 1.9 million new cancer cases were diagnosed in the U.S.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa